What question did this study set out to answer?

To investigate the role and mechanism of METTL16 in ischemic stroke and its effect on TIPARP.

April 13, 2026Open Access

METTL16 Promotes Cerebral Ischemia-Reperfusion Injury via m6A-Dependent Upregulation of TIPARP

Key Points

To investigate the role and mechanism of METTL16 in ischemic stroke and its effect on TIPARP.
Utilized a transient middle cerebral artery occlusion (MCAO) model in adult male mice.
Administered shRNA to knock down METTL16 post-reperfusion.
Assessed infarct volume, neurological function, and apoptosis through various tests.
Evaluated the METTL16-TIPARP interaction and m6A modification.
Conducted rescue experiments by overexpressing TIPARP in METTL16-depleted cells.
METTL16 knockdown reduced infarct volume and improved neurological function after MCAO.
Depletion of METTL16 protected neurons and astrocytes from OGD-induced apoptosis.
METTL16 increased TIPARP mRNA stability through m6A modification, upregulating TIPARP protein expression.
TIPARP overexpression negated the protective effects of METTL16 knockdown.

Abstract

Background: Ischemic stroke leads to severe cerebral ischemia/reperfusion (I/R) injury, resulting in neuronal death and neurological deficits. The N 6 -methyladenosine (m 6 A) methyltransferase METTL16 has emerged as a key regulator of RNA metabolism, but its specific role and mechanism in ischemic stroke remain unclear. Methods: A transient middle cerebral artery occlusion (MCAO) model was established in adult male C57BL/6J mice. METTL16 was knocked down via intracerebroventricular injection of shRNA-expressing lentivirus at 6 hours post-reperfusion. Cerebral infarct volume (TTC staining), neurological function (mNSS, adhesive removal, corner-turning, and rotarod tests), histopathology (H&E, TUNEL, Nissl, NeuN), and apoptosis-related protein expression were evaluated. Primary cortical neurons and astrocytes were subjected to oxygen-glucose deprivation (OGD). Cell apoptosis, LDH release, inflammatory cytokines (TNF-α, IL-1β), and synaptic protein (Synapsin-1, PSD-95) expression were assessed. The METTL16-TIPARP interaction and m 6 A modification were analyzed by RIP and m 6 A-RIP-qPCR. Protein stability was determined using cycloheximide chase assay. Rescue experiments were performed by overexpressing TIPARP in METTL16-depleted cells. Results: METTL16 knockdown significantly reduced infarct volume, attenuated neuronal apoptosis and inflammation, and improved sensorimotor and coordination functions after MCAO. In vitro, METTL16 depletion protected neurons and astrocytes from OGD-induced apoptosis, cytokine release, and synaptic damage. Mechanistically, METTL16 directly bound to TIPARP mRNA and enhanced its m 6 A modification, thereby stabilizing TIPARP transcripts and upregulating TIPARP protein expression. Critically, TIPARP overexpression completely abolished the protective effects of METTL16 knockdown against OGD-induced apoptosis and synaptic impairment. Conclusion: METTL16 promotes cerebral I/R injury by stabilizing TIPARP mRNA via m 6 A methylation, leading to elevated TIPARP expression. The METTL16-m 6 A-TIPARP axis represents a novel pathogenic mechanism and a potential therapeutic target for ischemic stroke. Keywords: stroke, neurons, astrocytes, METTL16, RNA methylation, TIPARP

Bookmark

View Full Paper

Cite This Study

Xiang et al. (Wed,) studied this question.

synapsesocial.com/papers/69dc89183afacbeac03eac83 https://doi.org/https://doi.org/10.2147/ijgm.s561723

Bookmark

View Full Paper